Reflections on eosinophils and flame figures: Where there's smoke there's not necessarily Wells syndrome

Archives of Dermatology

Volumn 142, Issue 9, 2006, Pages 1215-1218

  Leiferman, Kristin M ^a   Peters, Margot S ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

ATOPIC DERMATITIS; DERMATITIS; EDITORIAL; EOSINOPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURIGO; URTICARIA;

DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; SYNDROME;

EID: 33748774654     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.9.1215     Document Type: Editorial

References (28)

1. Leiferman KM, Peters MS, Gleich GJ. Eosinophils in cutaneous diseases. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine. Vol 1. 6th ed. New York, NY: McGraw-Hill Inc; 2003:959-966.
2. Moossavi M, Mehregan DR. Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol. 2003;42:62-67.
3. Leiferman KM, Peters MS, Gleich GJ. The eosinophil and cutaneous edema. J Am Acad Dermatol. 1986;15:513-517.
4. Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983;81:39-43.
5. Peters MS, Winkelmann RK, Greaves MW, Kephart GM, Gleich GJ. Extracellular deposition of eosinophil granule major basic protein in pressure urticaria. J Am Acad Dermatol. 1987;16:513-517.
6. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med. 1984;310:1621-1626.
7. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57:46-56.
8. Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol. 1991;24:1101-1112.
9. Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006;142:155-161.
10. Noguchi H, Kephart GM, Colby TV, Gleich GJ. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol. 1992;140:521-528.
11. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. In: Adkinson NFJr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, eds. Middleton's Allergy: Principles and Practice. Vol 1. 6th ed. St Louis, Mo: Mosby-Year Book Inc; 2003:305-332.
12. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147-174.
13. Davis MD, Plager DA, George TJ, Weiss EA, Gleich GJ, Leiferman KM. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol. 2003;112:988-994.
14. Leiferman KM, Plager DA, Gleich GJ. Eosinophils and atopic dermatitis. In: Bieber T, Leung DY, eds. Atopic Dermatitis. New York, NY: Marcel Dekker; 2002:327-355.
15. Jacoby DB, Gleich GJ, Fryer AD. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest. 1993;91:1314-1318.
16. Costello RW, Jacoby DB, Gleich GJ, Fryer AD. Eosinophils and airway nerves in asthma. Histol Histopathol. 2000;15:861-868.
17. Peters MS, Schroeter AL, Gleich GJ. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol. 1983;109:141-148.
18. Stern JB, Sobel HJ, Rotchford JP. Wells' syndrome: is there collagen damage in the flame figures? J Cutan Pathol. 1984;11:501-505.
19. Espana A, Sanz ML, Sola J, Gil P. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol. 1999;140:127-130.
20. Davis MD, Brown AC, Blackston RD, et al. Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation. J Am Acad Dermatol. 1998;38:919-928.
21. Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: still more heterogeneity. Curr Opin Immunol. 2005;17:679-684.
22. Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet. 2002;359:1577-1578.
23. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201-1214.
24. Simon HU, Plotz SG, Simon D, Dummer R, Blaser K. Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia. Int Arch Allergy Immunol. 2001;124:242-245.
25. Butterfield JH, Leiferman KM, Gleich GJ. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy. 1993;23:571-580.
26. Wells GC, Smith NP. Eosinophilic cellulitis. Br J Dermatol. 1979;100:101-109.
27. Winfield H, Lain E, Horn T, Hoskyn J. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection. Arch Dermatol. 2006;142:218-220.
28. Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol. 2006;142:1157-1161.